Search
Search Funnelback University
Your query has been expanded to `News and Events` |u:www.enterprize.cam.ac.uk. Search for `News and Events` |u:www.enterprise.cam.ac.uk instead.
31 -
50 of
62
search results for `News and Events` |u:www.enterprise.cam.ac.uk or `News and Events` |u:www.enterprize.cam.ac.uk
Fully-matching results
-
Fluidity One system Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/fluidity-one-system/feed/25 Jul 2024: camenterprise.dev.twkmedia.com/?post_type=news&p=11819 pFluidic Analytics Ltd, a Cambridge Enterprise portfolio company, has raised $31 million to continue developing its transformational products for characterising proteins ... 342px) 100vw, 342px" -
‘Mid-sized’ firms key to UK manufacturing and economy – Cambridge…
https://www.enterprise.cam.ac.uk/news/mid-sized-firms-key-to-uk-manufacturing/23 Oct 2020: Society for the encouragement of Arts, Manufactures and Commerce (RSA) and supported by Lloyds banking group. ... France – and continue the spiral of decline we are currently seeing in UK manufacturing.
-
University of Cambridge Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/university-of-cambridge/feed/25 Jul 2024: cam.ac.uk/news/lab-grown-mini-guts-could-help-in-development-of-new-and-more-personalised-treatments-for-crohns-disease/ Gianluca D'Uva Tue, 11 Jun 2024 16:20:20 ... 342px) 100vw, 342px" //a/div /div /blockquote /div pRead the full release a href="https:/ -
Sentinel Oncology awarded Eurostars grant for research and…
https://www.enterprise.cam.ac.uk/news/sentinel-oncology-awarded-eurostars-grant-for-rd/23 Oct 2020: Current drug treatments for AML suffer from poor efficacy and numerous unwanted side-effects. ... The Eurostars programme was established to assist small and medium enterprises (SMEs) in obtaining research and development funding.
-
protein social network Archives – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/tag/protein-social-network/feed/25 Jul 2024: camenterprise.dev.twkmedia.com/?post_type=news&p=11819 pFluidic Analytics Ltd, a Cambridge Enterprise portfolio company, has raised $31 million to continue developing its transformational products for characterising proteins ... 342px) 100vw, 342px" -
Cambridge and Nanjing launch strategic collaboration – Cambridge…
https://www.enterprise.cam.ac.uk/news/cambridge-and-nanjing-launch-strategic-collaboration/23 Oct 2020: As well as supporting health and wellbeing in new cities, the new Centre will help deliver efficient energy use through its academic and entrepreneurial activities. ... The Vice-Chancellor was joined by Professor Sir Mark Welland, Head of the
-
Annual awards recognise Cambridge innovation and excellence –…
https://www.enterprise.cam.ac.uk/news/annual-awards-recognise-cambridge-innovation-and-excellence/23 Feb 2023: million Series A Funding with Medicxi and Johnson & Johnson Innovation to develop antibodies with anticoagulant properties. ... into the discovery of first-in-class drugs in oncology and other diseases.
-
Academy award for founder and CEO of Cambridge spin-out – Cambridge…
https://www.enterprise.cam.ac.uk/news/academy-award-for-founder-and-ceo-of-cambridge-spin-out/22 Feb 2023: 10 July 2019. Academy award for founder and CEO of Cambridge spin-out. ... in applications ranging from power supplies for consumer electronics to LED drives, data centres and wireless chargers.
-
A look at golden shares and anti-dilution provisions – Cambridge…
https://www.enterprise.cam.ac.uk/news/a-look-at-golden-shares-and-anti-dilution-provisions/23 Oct 2020: Hockaday, CEO, Isis Innovation ltd and Tony Hickson, Managing Director Technology Transfer, Imperial Innovations plc. ... that UK universities take too much equity in spin-outs and more equity should be retained by founding entrepreneurs to incentivise
-
Spin-out Morphogen-IX announces appointment of CEO and SAB members –…
https://www.enterprise.cam.ac.uk/news/spin-morphogen-ix-announces-appointment-ceo-sab-members/23 Oct 2020: 28 June 2018. Spin-out Morphogen-IX announces appointment of CEO and SAB members. ... The SAB comprises leading international experts in the field of PAH research, experimental medicine and clinical trials:.
-
Biomarker signature identified for Crohn's and ulcerative colitis …
https://www.enterprise.cam.ac.uk/news/biomarker-signature-identified-for-crohns-and-ulcerative-colitis/23 Oct 2020: Share:. Crohn’s disease and ulcerative colitis are increasingly common, chronic forms of inflammatory bowel disease which predominantly affect young adults. ... Cambridge Enterprise, the University’s commercialisation group, is seeking a commercial
-
Cambridge Graphene Centre and Plastic Logic announce partnership –…
https://www.enterprise.cam.ac.uk/news/cambridge-graphene-centre-and-plastic-logic-announce-partnership/23 Oct 2020: Share:. A formal collaboration between Cambridge’s Graphene Centre, and the University spin-out company, Plastic Logic, has been announced. ... The research of the Centre aims to find ways of manufacturing and optimising graphene and related materials
-
GeoSpock captures space and time to deliver database for IoT –…
https://www.enterprise.cam.ac.uk/news/geospock-captures-space-and-time-to-deliver-database-for-iot/23 Oct 2020: 16 November 2015. GeoSpock captures space and time to deliver database for IoT. ... A new generation of applications use time and place to deliver a customer service.
-
Overnight home use of artificial pancreas ‘feasible and beneficial’ – …
https://www.enterprise.cam.ac.uk/news/overnight-home-use-of-artificial-pancreas-feasible-and-beneficial/23 Oct 2020: The success of this trial means that larger and longer studies are already in the pipeline. ... The findings from this study are positive and are certainly worth investigating further.
-
Spin-out PredictImmune announces new patent grants and allowances in…
https://www.enterprise.cam.ac.uk/news/spin-predictimmune-announces-new-patent-grants-allowances-uk-eu-canada/22 Feb 2023: 18 October 2018. Spin-out PredictImmune announces new patent grants and allowances in UK, EU, Canada. ... and immune mediated diseases, including ANCA-Associated Vasculitis (AAV) and Inflammatory Bowel Disease (IBD).
-
Enterprise Tuesday: investment and understanding funding methods –…
https://www.enterprise.cam.ac.uk/news/enterprise-tuesday-getting-investment-and-understanding-funding-methods/23 Oct 2020: She then moved to the US where she spearheaded multimedia productions for Intuit, The Learning Company and Standard&Poors. ... This evening’s lecture begins at 6pm and takes place in Lecture Theatre 0 at the Department of Engineering.
-
Horizon Discovery and Eight19 winners at Business Weekly awards –…
https://www.enterprise.cam.ac.uk/news/horizon-discovery-and-eight19-among-winners-at-business-weekly-awards/23 Oct 2020: The Business of the Year was chosen from all the final shortlisted companies and recognised a company which made the largest strides in 2011. ... lighting. By combining solar and mobile phone technology, Eight19 is bringing electricity directly to
-
Spin-out Sano Genetics raises £2.5m – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/cambridge-spin-out-sano-genetics-raises-2-5m-and-accelerates-research-into-long-covid/23 Feb 2023: 29 January 2021. Cambridge spin-out Sano Genetics raises £2.5m and accelerates research into long COVID. ... changing medicines and, in doing so, improve the outlook for people living with chronic and often debilitating conditions.
-
New treatments for pain and MS being developed in open innovation…
https://www.enterprise.cam.ac.uk/news/new-treatments-for-pain-and-ms-being-developed-in-open-innovation-programme/23 Oct 2020: 25 June 2013. New treatments for pain and MS being developed in open innovation programme. ... Stevenage Bioscience Catalyst is a strong model for the future of university and industry collaboration.”.
-
PhoreMost and The Wistar Institute collaborate to identify new…
https://www.enterprise.cam.ac.uk/news/phoremost-and-the-wistar-institute-collaborate-to-identify-new-druggable-targets/23 Oct 2020: 10 March 2016. PhoreMost and The Wistar Institute collaborate to identify new druggable targets. ... identify and de-orphan novel targets in cancer, ageing and the immune system.
Refine your results
Date
- 25 2020
- 24 Past year
- 22 Past 6 months
- 22 2024
- 21 Yesterday
- 21 Past 3 months
- 21 Past fortnight
- 21 Past month
- 21 Past week
- 7 2023
- 6 2022
- 2 2021
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.